Chugai Pharmaceutical , Ltd. Profit Margin

Chugai Pharmaceutical , Ltd. (CHGCY) currently reports a profit margin of 35.62% as of September 2026. That compares with 32.73% in the prior-year period — up 8.8% year over year. That is above the sector sector average of 13.2%. Use the charts on this page to explore Chugai Pharmaceutical , Ltd.'s profit margin history and peer comparisons.

Chugai Pharmaceutical , Ltd.'s profit margin increased from 32.73% to 35.62% — a 8.8% year-over-year increase (period ending September 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Chugai Pharmaceutical , Ltd.'s profit margin of 35.62% is higher than the its sector sector average of 13.2%. That is roughly 169.8% above the sector mean. A reading higher peers can reflect different growth expectations, capital structure, or profitability — so it is worth checking the peer comparison chart before drawing conclusions.

There is no universal 'good' profit margin, but Chugai Pharmaceutical , Ltd.'s current 35.62% should be judged against industry norms (sector average: 13.2%) and against CHGCY's own history. Strong, stable readings often indicate durable competitive advantage; volatile or declining ones deserve a closer look at margins and capital efficiency.

Start with the current profit margin of 35.62%, then check the historical chart for trend and the peer comparison chart for relative positioning. The sector average is 13.2%. From there, open related valuation or income-statement pages for Chugai Pharmaceutical , Ltd., and consider following CHGCY for alerts when major investors trade the stock.